Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Bateman-House

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The American Journal of Bioethics : AJOB|February 27, 2024
Fetal Therapies and Clinical Research: Beyond Risk and BenefitLesha D Shah, John Lantos, Cara Hunt, et al.
Journal of Epidemiology and Community Health|April 9, 2018
Expanded access: growing importance to public healthJan Borysowski, Abha Saxena, Alison Bateman-House, et al.
Innovations in Clinical Neuroscience|May 1, 2023
Implications of Pediatric Initiatives on CNS Drug Development for All Ages-2020 and Beyond: Second of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug DevelopmentGahan Pandina, Joan Busner, Joseph P Horrigan, et al.
Human Gene Therapy|November 15, 2023
The Lived Experience of Pediatric Gene Therapy: A Scoping ReviewLaura Kimberly, Cara Hunt, Katherine Beaverson, et al.
Medicine in Microecology|April 9, 2021
Fecal microbiota transplantation: Uses, questions, and ethicsZoya Grigoryan, Michael J Shen, Shaina W Twardus, et al.
Nature Biotechnology|April 4, 2019
What compassionate use means for gene therapiesCarolyn Riley Chapman, Kenneth I Moch, Andrew McFadyen, et al.
AJOB Empirical Bioethics|April 10, 2019
Single-Patient Expanded Access Requests: IRB Professionals' Experiences and PerspectivesCarolyn Riley Chapman, Jenni A Shearston, Kelly McBride Folkers, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC)Arthur Caplan, Alison Bateman-House, Joanne Waldstreicher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 14, 2021
Gene therapy companies have an ethical obligation to develop expanded access policiesLisa Kearns, Carolyn Riley Chapman, Kenneth I Moch, et al.
Pediatric Neurology|December 13, 2024
Lived Experience of Patients and Caregivers in Rare Genetic Neurological Gene Therapy Clinical Trials in ChildrenAlison Bateman-House, Kirsten Cowley, Vivian Fernandez, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The American Journal of Bioethics : AJOB|February 27, 2024
Fetal Therapies and Clinical Research: Beyond Risk and BenefitLesha D Shah, John Lantos, Cara Hunt, et al.
Journal of Epidemiology and Community Health|April 9, 2018
Expanded access: growing importance to public healthJan Borysowski, Abha Saxena, Alison Bateman-House, et al.
Innovations in Clinical Neuroscience|May 1, 2023
Implications of Pediatric Initiatives on CNS Drug Development for All Ages-2020 and Beyond: Second of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug DevelopmentGahan Pandina, Joan Busner, Joseph P Horrigan, et al.
Human Gene Therapy|November 15, 2023
The Lived Experience of Pediatric Gene Therapy: A Scoping ReviewLaura Kimberly, Cara Hunt, Katherine Beaverson, et al.
Medicine in Microecology|April 9, 2021
Fecal microbiota transplantation: Uses, questions, and ethicsZoya Grigoryan, Michael J Shen, Shaina W Twardus, et al.
Nature Biotechnology|April 4, 2019
What compassionate use means for gene therapiesCarolyn Riley Chapman, Kenneth I Moch, Andrew McFadyen, et al.
AJOB Empirical Bioethics|April 10, 2019
Single-Patient Expanded Access Requests: IRB Professionals' Experiences and PerspectivesCarolyn Riley Chapman, Jenni A Shearston, Kelly McBride Folkers, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC)Arthur Caplan, Alison Bateman-House, Joanne Waldstreicher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 14, 2021
Gene therapy companies have an ethical obligation to develop expanded access policiesLisa Kearns, Carolyn Riley Chapman, Kenneth I Moch, et al.
Pediatric Neurology|December 13, 2024
Lived Experience of Patients and Caregivers in Rare Genetic Neurological Gene Therapy Clinical Trials in ChildrenAlison Bateman-House, Kirsten Cowley, Vivian Fernandez, et al.
Pageof 5